Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Humans with inherited T cell CD28 deficiency are susceptible to skin papillomaviruses but are otherwise healthy.
Béziat V, Rapaport F, Hu J, Titeux M, Bonnet des Claustres M, Bourgey M, Griffin H, Bandet É, Ma CS, Sherkat R, Rokni-Zadeh H, Louis DM, Changi-Ashtiani M, Delmonte OM, Fukushima T, Habib T, Guennoun A, Khan T, Bender N, Rahman M, About F, Yang R, Rao G, Rouzaud C, Li J, Shearer D, Balogh K, Al Ali F, Ata M, Dabiri S, Momenilandi M, Nammour J, Alyanakian MA, Leruez-Ville M, Guenat D, Materna M, Marcot L, Vladikine N, Soret C, Vahidnezhad H, Youssefian L, Saeidian AH, Uitto J, Catherinot É, Navabi SS, Zarhrate M, Woodley DT, Jeljeli M, Abraham T, Belkaya S, Lorenzo L, Rosain J, Bayat M, Lanternier F, Lortholary O, Zakavi F, Gros P, Orth G, Abel L, Prétet JL, Fraitag S, Jouanguy E, Davis MM, Tangye SG, Notarangelo LD, Marr N, Waterboer T, Langlais D, Doorbar J, Hovnanian A, Christensen N, Bossuyt X, Shahrooei M, Casanova JL. Béziat V, et al. Among authors: bonnet des claustres m. Cell. 2021 Jul 8;184(14):3812-3828.e30. doi: 10.1016/j.cell.2021.06.004. Epub 2021 Jul 1. Cell. 2021. PMID: 34214472 Free PMC article.
Emerging drugs for the treatment of epidermolysis bullosa.
Titeux M, Bonnet des Claustres M, Izmiryan A, Ragot H, Hovnanian A. Titeux M, et al. Among authors: bonnet des claustres m. Expert Opin Emerg Drugs. 2020 Dec;25(4):467-489. doi: 10.1080/14728214.2020.1839049. Epub 2020 Dec 14. Expert Opin Emerg Drugs. 2020. PMID: 33094671 Review.
Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses.
Barbieux C, Bonnet des Claustres M, Fahrner M, Petrova E, Tsoi LC, Gouin O, Leturcq F, Nicaise-Roland P, Bole C, Béziat V, Bourrat E, Schilling O, Gudjonsson JE, Hovnanian A. Barbieux C, et al. Among authors: bonnet des claustres m. J Allergy Clin Immunol. 2022 Apr;149(4):1358-1372. doi: 10.1016/j.jaci.2021.08.024. Epub 2021 Sep 17. J Allergy Clin Immunol. 2022. PMID: 34543653 Free article.
Duality of Netherton syndrome manifestations and response to ixekizumab.
Barbieux C, Bonnet des Claustres M, de la Brassinne M, Bricteux G, Bagot M, Bourrat E, Hovnanian A. Barbieux C, et al. Among authors: bonnet des claustres m. J Am Acad Dermatol. 2021 May;84(5):1476-1480. doi: 10.1016/j.jaad.2020.07.054. Epub 2020 Jul 18. J Am Acad Dermatol. 2021. PMID: 32692997 No abstract available.
Dystrophic epidermolysis bullosa pruriginosa: a new case series of a rare phenotype unveils skewed Th2 immunity.
Darbord D, Hickman G, Pironon N, Barbieux C, Bonnet-des-Claustres M, Titeux M, Miskinyte S, Cordoliani F, Vignon-Pennamen MD, Amode R, Hovnanian A, Bourrat E. Darbord D, et al. Among authors: bonnet des claustres m. J Eur Acad Dermatol Venereol. 2022 Jan;36(1):133-143. doi: 10.1111/jdv.17671. Epub 2021 Oct 15. J Eur Acad Dermatol Venereol. 2022. PMID: 34543471
Secukinumab Therapy for Netherton Syndrome.
Luchsinger I, Knöpfel N, Theiler M, Bonnet des Claustres M, Barbieux C, Schwieger-Briel A, Brunner C, Donghi D, Buettcher M, Meier-Schiesser B, Hovnanian A, Weibel L. Luchsinger I, et al. Among authors: bonnet des claustres m. JAMA Dermatol. 2020 Aug 1;156(8):907-911. doi: 10.1001/jamadermatol.2020.1019. JAMA Dermatol. 2020. PMID: 32459284 Free PMC article.